Company Overview of Numerate, Inc.
Numerate, Inc., a biotechnology company, develops a drug engineering platform. Its drug engineering platform is used to design and develop small molecule therapeutics. The company’s drug engineering platform is also applied to various therapeutic programs, such as multi-targeted type 2 diabetes therapy and medicine for HIV. Numerate, Inc. was incorporated in 2007 and is based in San Bruno, California.
1150 Bayhill Drive
San Bruno, CA 94066
Founded in 2007
Key Executives for Numerate, Inc.
Similar Private Companies By Industry
|Labrys Biologics, Inc.||United States|
|Core Prognostex, Inc.||United States|
|AuraZyme Pharmaceuticals, Inc.||United States|
|CardioCreate, Inc.||United States|
|CellzDirect, Inc.||United States|
Recent Private Companies Transactions
May 23, 2014
December 31, 2013
To contact Numerate, Inc., please visit www.numerate.com. Company data is provided by Capital IQ. Please use this form to report any data issues.